View Item 

Show simple item record

Overt Diabetic Neuropathy: Repair of Axo-glial Dysjunction and Axonal Atrophy by Aldose Reductase Inhibition and its Correlation to Improvement in Nerve Conduction Velocity
dc.contributor.authorSima, Anders A. F.en_US
dc.contributor.authorPrashar, A.en_US
dc.contributor.authorNathaniel, V.en_US
dc.contributor.authorBril, Veraen_US
dc.contributor.authorWerb, M. R.en_US
dc.contributor.authorGreene, Douglas A.en_US
dc.date.accessioned2010-06-01T21:04:57Z
dc.date.available2010-06-01T21:04:57Z
dc.date.issued1993-03en_US
dc.identifier.citationSima, A.A.F.; Prashar, A.; Nathaniel, V.; Bril, V.; Werb, M.R.; Greene, D.A. (1993). "Overt Diabetic Neuropathy: Repair of Axo-glial Dysjunction and Axonal Atrophy by Aldose Reductase Inhibition and its Correlation to Improvement in Nerve Conduction Velocity." Diabetic Medicine 10(2): 115-121. <http://hdl.handle.net/2027.42/74171>en_US
dc.identifier.issn0742-3071en_US
dc.identifier.issn1464-5491en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/74171
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=8458187&dopt=citationen_US
dc.format.extent648345 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights1993 Diabetes UKen_US
dc.subject.otherDiabetic Neuropathyen_US
dc.subject.otherAxo-glial Dysjunctionen_US
dc.subject.otherAxonal Atrophy Sural Nerve Conduction Velocityen_US
dc.subject.otherAldose Reductase Inhibitionen_US
dc.titleOvert Diabetic Neuropathy: Repair of Axo-glial Dysjunction and Axonal Atrophy by Aldose Reductase Inhibition and its Correlation to Improvement in Nerve Conduction Velocityen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelMedicine (General)en_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumMichigan Diabetes Research and Training Center and Departments of Pathology and Internal Medicine, University of Michigan, Ann Arbor, Michigan, U.S.A.en_US
dc.contributor.affiliationotherNeuropathology Research Laboratories, Department of Pathology, University of Manitoba, Winnipeg, Canadaen_US
dc.contributor.affiliationotherDepartment of Medicine, University of Toronto, Toronto, Ontario, Canadaen_US
dc.identifier.pmid8458187en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/74171/1/j.1464-5491.1993.tb00027.x.pdf
dc.identifier.doi10.1111/j.1464-5491.1993.tb00027.xen_US
dc.identifier.sourceDiabetic Medicineen_US
dc.identifier.citedreferenceGreene DA, Lattimer SA, Sima AAF. Sorbitol, phosphoinositides, and sodium-potassium-ATP-ase in the pathogenesis of diabetic complications. N Engl J Med 1987; 316: 599 – 606.en_US
dc.identifier.citedreferenceWinegrad AI. Does a common mechanism induce the diverse complications of diabetes? Diabetes 1987; 36: 396 – 406.en_US
dc.identifier.citedreferenceGreene DA, Lattimer-Greene SA, Sima AAF. Pathogenesis of diabetic neuropathy: role of altered phosphoinositide metabolism. Crit Rev Neurobiol 1989; 5: 143 – 219.en_US
dc.identifier.citedreferenceGreene DA, Sima AAF, Albers JW, Pfeifer M.. Diabetic Neuropathy In: Rifkin H., Porte D. Jr., eds, Ellenberg and Rifkin Diabetes Mellitus. New York: Elsevier, 1989. 710 – 755.en_US
dc.identifier.citedreferenceDyck PJ, Karnes JL, O'Brien P., Okazaki H., Lais A., Engelstad J.. The spatial distribution of fiber loss in diabetic polyneuropathy suggests ischemia. Ann Neurol 1986; 19: 440 – 444.en_US
dc.identifier.citedreferenceSima AAF, Nathaniel V., Prashar A., Bril, V. Greene, DA. Endoneurial microvessels in human diabetic neuropathy: Endothelial cell dysjunction and lack of treatment effect by aldose reductase inhibitor. Diabetes 1991; 40: 1090 – 1099.en_US
dc.identifier.citedreferencePirart J.. Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care 1978; 1: 168 – 188.en_US
dc.identifier.citedreference8 The DCCT Research Group. Factors in the development of diabetic neuropathy: baseline analysis of neuropathy in feasibility phase of diabetes control and complications trial (DCCT). Diabetes 1988; 37: 476 – 481.en_US
dc.identifier.citedreferenceMoser RE, Steenkiste AR, Dorman JS, Nielson VK, Bass EB, Manjoo Q., et al. Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh epidemiology of diabetes complications study. Diabetes 1989; 38: 1456 – 1461.en_US
dc.identifier.citedreferenceSima AAF. Can the BB-rat help to unravel diabetic neuropathy? Neuropath Appl Neurobiol 1985; 11: 253 – 264.en_US
dc.identifier.citedreferenceSima AAF, Brismar T., Yagihashi S.. Neuropathies encountered in the spontaneously diabetic BB-Wistar rat. In: PJ Dyck, PK Thomas, AK Asbury, AI Winegrad and D. Porte Jr., eds. Diabetic Neuropathy. Philadelphia: WB Saunders, 1987. 253 – 259.en_US
dc.identifier.citedreferenceGreene DA, Yagihashi S., Lattimer SA, Sima AAF. Na+K+-ATP-ase, conduction and myo-inositol in the insulin deficient BB-rat. Am J Phys 1984; 247: E534 – E539.en_US
dc.identifier.citedreferenceSima AAF, Brismar T.. Reversible diabetic nerve dysfunction: structural correlates to electrophysiological abnormalities. Ann Neurol 1985; 18: 21 – 29.en_US
dc.identifier.citedreferenceBrismar T., Sima AAF, Greene DA. Reversible and irreversible nodal dysfunction in diabetic neuropathy. Ann Neurol 1987; 21: 504 – 507.en_US
dc.identifier.citedreferenceSima AAF, Lattimer SA, Yagihashi S., Greene DA. Axoglial dysjunction. A novel structural lesion that accounts for poorly reversible slowing of nerve conduction in the spontaneously diabetic Bio-breeding rat. J Clin Invest 1986; 77: 474 – 484.en_US
dc.identifier.citedreferenceKinoshita JH. Cataracts in galactosemia. Invest Ophthalmol 1965; 4: 786 – 799.en_US
dc.identifier.citedreferenceGabbay KH, Merola LO, Field RA. Sorbitol pathway: presence in nerve and cord with substrate accumulation in diabetes. Science 1966; 151: 209 – 210.en_US
dc.identifier.citedreferenceDvornik D., Porte D. Jr. Aldose reductase inhibition: an approach to the prevention of diabetic complications. New York: McGraw-Hill, 1987.en_US
dc.identifier.citedreferenceGreene DA, Chakrabarti S., Lattimer SA, Sima AAF. Role of sorbitol accumulation and myo-inositol depletion in paranodal swelling of large myelinated nerve fibres in the insulin-deficient spontaneously diabetic Bio-breeding rat. Reversal by insulin replacement, an aldose reductase inhibitor and myo-inositol. J Clin Invest 1987; 79: 1479 – 1485.en_US
dc.identifier.citedreferenceGreene DA, Lattimer SA. Action of sorbinil in diabetic peripheral nerve: relationship of polyol (sorbitol) pathway inhibition to a myo-inositol mediated defect in sodium-potassium ATPase activity. Diabetes 1984; 33: 712 – 716.en_US
dc.identifier.citedreferenceSima AAF, Bril V., Nathaniel V., McEwen TAJ, Brown MB, Lattimer SA, et al. Regeneration and repair of myelinated fibers in sural nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil. N Engl J Med 1988; 319: 548 – 555.en_US
dc.identifier.citedreferenceSima AAF, Prashar A., Zhang W-X, Chakrabarti S., Greene DA. The preventive effect of long term aldose reductase inhibition (Ponalrestat) on nerve conduction and sural nerve structure in the spontaneously diabetic BB-rat. J Clin Invest 1990; 85: 1410 – 1420.en_US
dc.identifier.citedreferenceSima AAF, Cherian PV, Carson C., Kamijo M., Chakrabarti S.. Diabetic optic neuropathy and its prevention in the BB/W-rat with an aldose reductase inhibitor. Diabetes 1992; 41: ( suppl 1 ): 139A.en_US
dc.identifier.citedreferenceSima AAF, Nathaniel V., Bril V., McEwen TAJ, Greene DA. Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes. and demonstration of axo-glial dysjunction in human diabetic neuropathy. J Clin Invest 1988; 81: 349 – 364.en_US
dc.identifier.citedreference25 National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039 – 1057.en_US
dc.identifier.citedreferenceSima AAF, Brown MB, Prashar A., Chakrabarti C., Laudadio C., Greene DA. The reproducibility and sensitivity of sural nerve morphometry in the assessment of diabetic peripheral polyneuropathy. Diabetologia 1992; 35: 560 – 569.en_US
dc.identifier.citedreferenceBrismar T., Sima AAF. Changes in nodal function in nerve fibres of the spontaneously diabetic BB-Wistar rat. Potential clamp analysis. Acta Physiol Scand 1981; 1134: 499 – 506.en_US
dc.identifier.citedreferenceBischoff A.. Diabetische Neuropathie. Dtsch Med Wochenschr 1968; 93: 237 – 241.en_US
dc.identifier.citedreferenceYagihashi S.. Matsumaja M. Ultrastructural pathology of peripheral nerves in patients with diabetic neuropathy. Tohoku J Exp Med 1979; 129: 357 – 366.en_US
dc.identifier.citedreferenceDyck PJ, Lais A., Karnes JL, O'Brien P., Rizza R.. Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy. Ann Neurol 1986; 19: 425 – 439.en_US
dc.identifier.citedreferenceBehse F., Buchtal F., Carlsen F.. Nerve biopsy and conduction studies and diabetic neuropathy. J Neurol Neurosurg Psychiatry 1977; 40: 1072 – 1082.en_US
dc.identifier.citedreferenceMedori R., Autilio-Gambetti L., Jenich H., Gambetti P.. Changes in axonal size and slow axonal transport are related in experimental diabetic neuropathy. Neurology 1988; 38: 597 – 601.en_US
dc.identifier.citedreferenceMayer JH, Tomlinson DR. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin diabetic rats. Diabetologia 1983; 25: 433 – 438.en_US
dc.identifier.citedreferenceThomas PK, Wright DW, Tzebelikas E.. Amino acid uptake by dorsal root ganglia from streptozotocin-diabetic rats. J Neurol Neurosurg Psychiatry 1984; 47: 912 – 916.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1464-5491.1993.tb00027.x.pdf
Size:
633.1KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.